CatalystWireBeta

Niox Group

NIOX · AIM · Health Care · mcap £286m · 68.8p 1 open situation →

Beta Briefing, track record and signals & risks are not ready for Niox Group yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 1

Project milestones

NIOX PRO device rollout

CE/MHRA rollout begun; US, Japan submissions progressing

Next: US and Japan regulatory approvals for NIOX PRO

  1. 29 Sep 2026 CE/MHRA rollout begun; US, Japan submissions progressing
  2. 28 Jul 2026 CE Mark and MHRA obtained; US/Japan pending
  3. 24 Mar 2026 Launched; first sale December 2025; approvals pending
  4. 20 Jan 2026 Launched; first sale December 2025
Open the full view – chart and every step →

Closed · 4

Capital returnTender offer paid out · 29 Sep 2026 – 22 Oct 2026 Takeover targetOffer for the company went quiet · 11 Apr 2025 – 8 Oct 2025 +6% Insider conviction1 director buying £25k in 1 buy · 11 Apr 2025 – 10 Jul 2025 +6% Insider conviction2 directors buying £67k in 2 buys · 25 Oct 2024 – 23 Jan 2025 −8%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note